Related Experiment Video
Updated: Jun 25, 2026
09:31
Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells
C Jackaman1, S Cornwall, A M Lew
1School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.
The European Respiratory Journal
|March 3, 2009
Summary
Mesothelioma T-cell responses fail locally within tumors, not systemically. Targeting regulatory T-cells (Tregs) did not improve immunotherapy outcomes in this mesothelioma model.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Mesothelioma is a cancer associated with chronic inflammation.
- Tumor antigens are presented to T-cells, initiating an immune response.
- The tumor microenvironment contains various immune cells, including T-regulatory cells (Tregs).
Purpose of the Study:
- To determine when T-cell responses fail in mesothelioma.
- To identify potential targets for improved mesothelioma immunotherapies.
- To investigate the role of Tregs in mesothelioma progression and immunotherapy.
Main Methods:
- Utilized a murine model of asbestos-induced mesothelioma.
- Analyzed T-cell responses in tumor-infiltrating lymphocytes and lymphoid organs.
- Performed adoptive transfer experiments with Tregs.
- Assessed tumor growth with and without Treg depletion and immunotherapy (IL-2, IL-21).
Main Results:
- Potent anti-tumor CD8+ T-cell responses were generated but failed to control tumor growth within the tumor microenvironment, indicating local suppression.
- Systemic Tregs did not suppress anti-mesothelioma immune responses.
- Depletion of CD25+ Tregs did not impact tumor growth, even with immunotherapy.
Conclusions:
- Local suppression within the mesothelioma tumor microenvironment limits T-cell efficacy.
- Systemic Tregs play a minimal role in regulating anti-mesothelioma immunity.
- Targeting Tregs is unlikely to be an effective strategy for improving mesothelioma immunotherapy.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
02:17The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...